![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The European Investment Bank (EIB) granted Medincell a €40 million credit facility in November 2022, fully drawn since July 2023 The EIB has decided to remove two financial covenants(1) from the...
Regulatory News: Medincell’s (Paris:MEDCL) partner Teva Pharmaceuticals shared today the following information: About UZEDY® 2024 sales: $117 million with $43 million in Q4 + 17% compared to $100...
Regulatory News: Medincell (Paris:MEDCL): Event Date Annual results 2024-2025 (April 2024-March 2025) Tuesday, June 17, 2025 General Meeting Thursday, September 11, 2025 Half-Year results...
Article 223-16 du règlement Général de l’Autorité des Marchés Financiers Regulatory News: MedinCell (Paris:MEDCL) : Place de cotation : Euronext Paris, Compartiment B Code ISIN : FR0004065605...
Regulatory News: Medincell (Paris:MEDCL) joins the Euronext SBF 120 index, which includes the 120 largest companies listed on Euronext Paris, including the CAC 40 and most of the key players in...
Medincell (Paris:MEDCL) joins the Euronext SBF 120 index, which includes the 120 largest companies listed on Euronext Paris, including the CAC 40 and most of the key players in the French...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.26 | 1.6731016731 | 15.54 | 16.64 | 15.32 | 54069 | 15.9600853 | DE |
4 | -1.02 | -6.06420927467 | 16.82 | 17.2 | 15.1 | 58388 | 16.04721657 | DE |
12 | -1.8 | -10.2272727273 | 17.6 | 18.64 | 14.66 | 73922 | 16.56970157 | DE |
26 | 0.64 | 4.22163588391 | 15.16 | 19 | 14.54 | 70377 | 16.65820896 | DE |
52 | 6.86 | 76.7337807606 | 8.94 | 19 | 8.55 | 77392 | 14.78662888 | DE |
156 | 7.57 | 91.9805589307 | 8.23 | 19 | 4.73 | 53550 | 10.73541755 | DE |
260 | 9.18 | 138.670694864 | 6.62 | 20 | 4.35 | 49471 | 10.76068052 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions